Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Onkologie
|
October 10, 2009
Primary manifestation of small lymphocytic lymphoma in the prostate
Martin Fehr, Arnoud Templeton, Sergio Cogliatti, et al.
Breast Cancer Research and Treatment
|
September 8, 2012
Management of small HER2 overexpressing tumours
Arnoud Templeton, Alberto Ocaña, Boštjan Seruga, et al.
Complementary Medicine Research
|
October 27, 2017
[Erfahrungen am Lebensende: Eine Umfrage bei Ärzten und Pflegenden eines Spitals für anthroposophisch erweiterte Medizin]
Sabine Klein, Sara Kohler, Daniel Krüerke, et al.
Breast Cancer Research and Treatment
|
February 22, 2016
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
Alberto Ocaña, Javier Pérez-Peña, Laura Díez-González, et al.
Cancer Medicine
|
September 30, 2016
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma
Leila Khoja, Eshetu G Atenafu, Arnoud Templeton, et al.
European Urology
|
July 12, 2011
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome
Martin Kälin, Igor Cima, Ralph Schiess, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 1, 2023
Early response monitoring during [<sup>177</sup>Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study
Moritz C Neubauer, Guillaume P Nicolas, Andreas Bauman, et al.
Onkologie
|
May 27, 2010
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)
Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, et al.
International Journal of Cancer
|
August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
Natalie Turner, Hui-Li Wong, Arnoud Templeton, et al.
The Oncologist
|
April 7, 2019
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Aaron R Hansen, Ian F Tannock, Arnoud Templeton, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Onkologie
|
October 10, 2009
Primary manifestation of small lymphocytic lymphoma in the prostate
Martin Fehr, Arnoud Templeton, Sergio Cogliatti, et al.
Breast Cancer Research and Treatment
|
September 8, 2012
Management of small HER2 overexpressing tumours
Arnoud Templeton, Alberto Ocaña, Boštjan Seruga, et al.
Complementary Medicine Research
|
October 27, 2017
[Erfahrungen am Lebensende: Eine Umfrage bei Ärzten und Pflegenden eines Spitals für anthroposophisch erweiterte Medizin]
Sabine Klein, Sara Kohler, Daniel Krüerke, et al.
Breast Cancer Research and Treatment
|
February 22, 2016
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
Alberto Ocaña, Javier Pérez-Peña, Laura Díez-González, et al.
Cancer Medicine
|
September 30, 2016
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma
Leila Khoja, Eshetu G Atenafu, Arnoud Templeton, et al.
European Urology
|
July 12, 2011
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome
Martin Kälin, Igor Cima, Ralph Schiess, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 1, 2023
Early response monitoring during [<sup>177</sup>Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study
Moritz C Neubauer, Guillaume P Nicolas, Andreas Bauman, et al.
Onkologie
|
May 27, 2010
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02)
Thomas Ruhstaller, Arnoud Templeton, Karin Ribi, et al.
International Journal of Cancer
|
August 14, 2015
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
Natalie Turner, Hui-Li Wong, Arnoud Templeton, et al.
The Oncologist
|
April 7, 2019
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Aaron R Hansen, Ian F Tannock, Arnoud Templeton, et al.
Page
of 3